Avian influenza can be defined as the disease caused by infection by the bird flu Type-A virus. These viruses are found commonly in aquatic birds and they can cause infection in domestic poultry and other species of birds. Based on the protein present on the virus surface, the influenza Type-A virus can be sub-classified into neuraminidase (NA) and hemagglutinin (HA). Based on their molecular characteristics and ability to cause disease and mortality in chicken, the avian influenza virus can be classified into highly pathogenic and low pathogenic. However, both are known to spread rapidly in poultry. The low-pathogenic avian influenza virus does not manifest any signs of a disease. It only exhibits mild illnesses such as decline in egg production and ruffled feathers. However, infection by the highly pathogenic influenza virus leads to high mortality. The avian influenza virus is also known to cause infection in humans when the virus is inhaled or when it enters the eyes, the nose, or the mouth. The avian influenza virus is shed through saliva, feces, and mucous. Avian influenza vaccines are employed as a tool to combat financial losses caused due to the infection.
The growing prevalence of diseases, primarily in developing regions, is a major cause of over 90% of mortality in poultry. High demand for poultry for consumption, ongoing research for the development of effective vaccines for disease prevention, and the increasing number of outbreaks contribute to the global avian influenza vaccines market. However, rapid deterioration of these vaccines at room temperature within a couple of hours makes them unsuitable for transportation to distant villages. In addition, according to the U.S. Department of Agriculture (U.S. DA), the vaccines currently available do not match the required levels of efficacy and hence, they should not be used for treating outbreaks of avian influenza. These factors are likely to restrain the avian influenza vaccines market during the forecast period. Furthermore, lack of awareness about the disease among people maintaining poultry is projected to hamper the avian influenza vaccines market in the near future.
The global avian influenza vaccines market can be segmented based on vaccine type, strain, application, and region. In terms of vaccine type, the avian influenza vaccines market can be classified into inactivated vaccines, live recombinant vaccines, and combination vaccines. Based on strain, the avian influenza vaccines market can be divided into H5 strain, H7 strain, and H9 strain. In terms of application, the avian influenza vaccines market can be segregated into chicken, duck & goose, and others.
Geographically, the global avian influenza vaccines market can be segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to account for the largest market share during the forecast period, owing to ongoing research and development activities and growing awareness among people in the region. Europe is projected to account for the second-largest share of the global market, in terms of revenue, from 2018 to 2026. The avian influenza vaccines market in Asia Pacific is expected to expand at a high CAGR during the forecast period. This can be attributed to significant contribution of developing economies such as India and China. Growing dependence on poultry as the key source of proteins in diet and rising prevalence of the avian influenza disease in the region drive the avian influenza vaccines market in Asia Pacific.
Leading players operating in the global avian influenza vaccines market are Merial (a Sanofi Company), QianYuanHao Biological Corporation Limited, DHN, Harbin Veterinary Research Institute (HVRI), CEVA, Elanco, The Qingdao Yebio Biological Engineering Co., Ltd., Zoetis, Inc., FATRO S.p.A., CAVAC, Ringpu Biology, Merck Animal Health (a subsidiary of Merck & Co. Inc.), and Boehringer Ingelheim GmbH.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.